180 related articles for article (PubMed ID: 9886327)
1. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype.
Haskovec C; Ponzetto C; Polák J; Maritano D; Zemanová Z; Serra A; Michalová K; Klamová H; Cermák J; Saglio G
Br J Haematol; 1998 Dec; 103(4):1104-8. PubMed ID: 9886327
[TBL] [Abstract][Full Text] [Related]
2. Blast crisis of Philadelphia chromosome-positive chronic myeloid leukaemia carrying micro-bcr breakpoint (e19a2 and e191a).
Ohsaka A; Hoshino S; Kobayashi M; Kudo H; Kawaguchi R
Br J Haematol; 2002 Jul; 118(1):251-4. PubMed ID: 12100156
[TBL] [Abstract][Full Text] [Related]
3. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
Arana-Trejo RM; Ruíz Sánchez E; Ignacio-Ibarra G; Báez de la Fuente E; Garces O; Gómez Morales E; Castro Granados M; Ovilla Martínez R; Rubio-Borja ME; Solís Anaya L; Herrera P; Delgado Llamas J; Kofman S
Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
[TBL] [Abstract][Full Text] [Related]
4. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
[TBL] [Abstract][Full Text] [Related]
6. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.
Barnes DJ; Melo JV
Acta Haematol; 2002; 108(4):180-202. PubMed ID: 12432215
[TBL] [Abstract][Full Text] [Related]
8. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
9. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
[TBL] [Abstract][Full Text] [Related]
10. De nove Philadelphia chromosome-positive myelodysplastic syndromes with complex karyotype and p230
Ma J; Guan J; Chen B
Hematology; 2023 Dec; 28(1):2220220. PubMed ID: 37288817
[TBL] [Abstract][Full Text] [Related]
11. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H
Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia chromosome and/or bcr-abl mRNA-positive primary thrombocytosis: morphometric evidence for the transition from essential thrombocythaemia to chronic myeloid leukaemia type of myeloproliferation.
Pajor L; Kereskai L; Zsdrál K; Nagy Z; Vass JA; Jáksó P; Radványi G
Histopathology; 2003 Jan; 42(1):53-60. PubMed ID: 12493025
[TBL] [Abstract][Full Text] [Related]
14. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
15. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
16. e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases.
Mondal BC; Majumdar S; Dasgupta UB; Chaudhuri U; Chakrabarti P; Bhattacharyya S
J Clin Pathol; 2006 Oct; 59(10):1102-3. PubMed ID: 17021137
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia.
Baines P; Austin S; Fisher J; Owen-Jones E; Lee-Jones L; Throp D; Mckinley M; Hoy T; Mills K; Thompson P; Burnett A
Leuk Res; 2002 Nov; 26(11):997-1005. PubMed ID: 12363468
[TBL] [Abstract][Full Text] [Related]
18. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
Batista DA; Hawkins A; Murphy KM; Griffin CA
Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
[TBL] [Abstract][Full Text] [Related]
19. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
20. Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.
Verstovsek S; Lin H; Kantarjian H; Saglio G; De Micheli D; Pane F; Garcia-Manero G; Intrieri M; Rotoli B; Salvatore F; Guo JQ; Talpaz M; Specchia G; Pizzolo G; Liberati AM; Cortes J; Quackenbush RC; Arlinghaus RB
Cancer; 2002 May; 94(9):2416-25. PubMed ID: 12015767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]